WDIV Volume Spikes 13× as Pfizer, Oneok Move

SPDR S&P Global Dividend ETF (WDIV) has seen unusual trading volume, which is 13× higher than its average daily volume.

Within WDIV’s top holdings, Pfizer Inc. (PFE), a 1.4% weight, moved higher in focus after the company detailed progress on two early-stage clinical programs: a new Phase 1 study of experimental drug PF-07328948 to better understand its behavior in the body, and an actively recruiting Phase 1b/2 trial of PF-08634404 in advanced kidney cancer that could bolster Pfizer’s long-term oncology pipeline. Another key holding, Oneok Inc. (OKE), also at 1.4% weight, was in the news as Barclays reiterated a Hold rating with an $82 price target, signaling a neutral stance even as the stock trades above that level and consensus expectations remain at a Moderate Buy with a slightly higher average target price.